每年研究成果
每年研究成果
Description
Additional file 6: Figure S6. DETC inhibitor used in vitro and in vivo. (A) (Left) U87MG spheres were treated with different doses of DETC as indicated. The cell lysates were analyzed via western blot. The statistic results (Right) were shown. (B) Mice that received U87MG-r#10 cells were randomly treated with TMZ or TMZ/DETC for 5 consecutive days. Representative images of IHC staining in which the specific protein levels of the resistant xenografts were analyzed. *Pâ
| 可用日期 | 2019 |
|---|---|
| 發行者 | Figshare |
研究成果
- 1 文章
-
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chien, C. H., Chuang, J. Y., Yang, S. T., Yang, W. B., Chen, P. Y., Hsu, T. I., Huang, C. Y., Lo, W. L., Yang, K. Y., Liu, M. S., Chu, J. M., Chung, P. H., Liu, J. J., Chou, S. W., Chen, S. H. & Chang, K. Y., 10月 19 2019, 於: Journal of Biomedical Science. 26, 1, 77.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取27 引文 斯高帕斯（Scopus）